Conversion of tuberculosis screening tests during biological therapy in patients with rheumatic diseases: what’s beyond screening values?

V. Sadovici-Bobeica (Chisinau, Republic of Moldova), V. Salaru (Chisinau, Republic of Moldova), L. Mazur-Nicorici (Chisinau, Republic of Moldova), M. Garabajiu (Chisinau, Republic of Moldova), T. Rotaru (Chisinau, Republic of Moldova), M. Mazur (Chisinau, Republic of Moldova)

Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Session: Tuberculosis transmission and screening strategies
Session type: Poster Discussion
Number: 5280
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Sadovici-Bobeica (Chisinau, Republic of Moldova), V. Salaru (Chisinau, Republic of Moldova), L. Mazur-Nicorici (Chisinau, Republic of Moldova), M. Garabajiu (Chisinau, Republic of Moldova), T. Rotaru (Chisinau, Republic of Moldova), M. Mazur (Chisinau, Republic of Moldova). Conversion of tuberculosis screening tests during biological therapy in patients with rheumatic diseases: what’s beyond screening values?. 5280

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Screening for tuberculosis in patients with rheumatic diseases commencing anti-TNF-α treatment: A regional survey
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012

Effectiveness of a tuberculosis screening program in rheumatic patients treated with immunossuppressants
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012

Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non- tuberculosis diseases
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013



Screening and monitoring of TB infection in rheumatological patients on biologics therapy
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021


Screening and monitoring of tuberculosis in patients on biologics treatment
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012

Diagnosis of tuberculosis in patients with psoriasis: the need for a modified approach
Source: Eur Respir J 2011; 37: 231-232
Year: 2011


Diagnosis of tuberculosis in patients with psoriasis: the need for a modified approach
Source: Eur Respir J 2011; 37: 232-233
Year: 2011


Are there any similarities between the skin and the blood tests with CFP10-ESAT6 in tuberculosis patients?
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013

Rare lung diseases in children: challenges for diagnosis and treatment
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021


Use of molecular-genetic methods in diagnostics and therapy of a tuberculosis (TB) at patients with HIV
Source: Annual Congress 2010 - Tuberculosis in special populations
Year: 2010

Managing tuberculosis in chronic kidney disease: An evaluation of patient treatment regimens
Source: Annual Congress 2011 - Tuberculosis in special populations
Year: 2011



Clustering of patients with end-stage chronic diseases by symptoms: a new approach to identify health needs.
Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases
Year: 2018




Case-finding for COPD: Developing strategies to identify patients at risk populations
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015

Tuberculosis screening in immigrants - is it worth doing?
Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Year: 2005


Challenges in the prevention, diagnosis, and treatment of tuberculosis in children
Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Year: 2019


Quantiferon test in the complex diagnosis of tuberculosis in patients with end-stage kidney disease
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020


Is tuberculosis different in elderly patients?
Source: Annual Congress 2007 - Epidemiology of tuberculosis II
Year: 2007